Circular peptides as a new class of ligands to modulate cannabinoid type 2 receptor signaling (#372)
Natasa Tomasevic
1
,
Fabiola S. Emser
1
,
Edin Muratspahic
1
2
,
Manuel Felkl
3
,
Christian F.W. Becker
3
,
Christian W. Gruber
1
- Institute for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
- Institute for Protein Design, University of Washington, Seattle, Washington, USA
- Institute of Biological Chemistry, University of Vienna, Vienna, Austria
Publish consent withheld
- Muratspahić, E. et al. Nature-Derived Peptides: A Growing Niche for GPCR Ligand Discovery. Trends in Pharmacological Sciences 40, 309-326 (2019).
- Muratspahić, E. et al. Harnessing cyclotides to design and develop novel peptide GPCR ligands. RSC Chemical Biology 1, 177-191 (2020).
- Li, X. et al. Crystal structure of the human cannabinoid receptor CB2. Cell 176, (2019).
- Di Marzo, V. New approaches and challenges to targeting the endocannabinoid system. Nature Reviews Drug Discovery 17, 623–639 (2018).